NRAS c.392A>G ;(p.H131R)

Variant ID: 1-115252248-T-C

NM_002524.4(NRAS):c.392A>G;(p.H131R)

This variant was identified in 23 publications

View GRCh38 version.




Publications:


Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows.

Bmc Medical Genomics
Sobahy, Turki M TM; Tashkandi, Ghassan G; Bahussain, Donya D; Al-Harbi, Raneem R
Publication Date: 2022-04-25

Variant appearance in text: NRAS: 392A>G
PubMed Link: 35468810
Variant Present in the following documents:
  • 12920_2022_1235_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Cancer Medicine
Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y
Publication Date: 2022-07

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 35393784
Variant Present in the following documents:
  • CAM4-11-2767-s001.xlsx, sheet 1
View BVdb publication page



A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.

Genome Research
Chen, Siwei S; Liu, Yuan Y; Zhang, Yingying Y; Wierbowski, Shayne D SD; Lipkin, Steven M SM; Wei, Xiaomu X; Yu, Haiyuan H
Publication Date: 2022-01

Variant appearance in text: NRAS: H131R
PubMed Link: 34963661
Variant Present in the following documents:
  • supp_gr.275437.121_Supplementary_Table_1.xlsx, sheet 3
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Integrated molecular drivers coordinate biological and clinical states in melanoma.

Nature Genetics
Conway, Jake R JR; Dietlein, Felix F; Taylor-Weiner, Amaro A; AlDubayan, Saud S; Vokes, Natalie N; Keenan, Tanya T; Reardon, Brendan B; He, Meng Xiao MX; Margolis, Claire A CA; Weirather, Jason L JL; Haq, Rizwan R; Schilling, Bastian B; Stephen Hodi, F F; Schadendorf, Dirk D; Liu, David D; Van Allen, Eliezer M EM
Publication Date: 2020-12

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 33230298
Variant Present in the following documents:
  • NIHMS1637640-supplement-SuppData1.xlsx, sheet 1
View BVdb publication page



Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.

Npj Breast Cancer
Yi, Zongbi Z; Rong, Guohua G; Guan, Yanfang Y; Li, Jin J; Chang, Lianpeng L; Li, Hui H; Liu, Binliang B; Wang, Wenna W; Guan, Xiuwen X; Ouyang, Quchang Q; Li, Lixi L; Zhai, Jingtong J; Li, Chunxiao C; Li, Lifeng L; Xia, Xuefeng X; Yang, Ling L; Qian, Haili H; Yi, Xin X; Xu, Binghe B; Ma, Fei F
Publication Date: 2020

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 33145402
Variant Present in the following documents:
  • 41523_2020_201_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.

Bmc Cancer
Ottaiano, Alessandro A; Scala, Stefania S; Normanno, Nicola N; Napolitano, Maria M; Capozzi, Monica M; Rachiglio, Anna Maria AM; Roma, Cristin C; Trotta, Anna Maria AM; D'Alterio, Crescenzo C; Portella, Luigi L; Romano, Carmela C; Cassata, Antonino A; Casaretti, Rossana R; Silvestro, Lucrezia L; Nappi, Anna A; Tafuto, Salvatore S; Avallone, Antonio A; De Stefano, Alfonso A; Tamburini, Mario M; Picone, Carmine C; Petrillo, Antonella A; Izzo, Francesco F; Palaia, Raffaele R; Albino, Vittorio V; Amore, Alfonso A; Belli, Andrea A; Pace, Ugo U; Di Marzo, Massimiliano M; Chiodini, Paolo P; Botti, Gerardo G; De Feo, Gianfranco G; Delrio, Paolo P; Nasti, Guglielmo G
Publication Date: 2019-09-09

Variant appearance in text: NRAS: H131R
PubMed Link: 31500586
Variant Present in the following documents:
  • Main text
  • 12885_2019_Article_6109.pdf
View BVdb publication page



Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

Scientific Reports
Borrero-Palacios, A A; Cebrián, A A; Gómez Del Pulgar, M T MT; García-Carbonero, R R; Garcia-Alfonso, P P; Aranda, E E; Elez, E E; López-López, R R; Cervantes, A A; Valladares, M M; Nadal, C C; Viéitez, J M JM; Guillén-Ponce, C C; Rodríguez, J J; Hernández, I I; García, J L JL; Vega-Bravo, R R; Puime-Otin, A A; Martínez-Useros, J J; Del Puerto-Nevado, L L; Rincón, R R; Rodríguez-Remírez, M M; Rojo, F F; García-Foncillas, J J
Publication Date: 2019-02-22

Variant appearance in text: NRAS: H131R
PubMed Link: 30796344
Variant Present in the following documents:
  • Main text
  • 41598_2019_Article_39291.pdf
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: NRAS: H131R
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 1
  • pone.0196434.s001.xlsx, sheet 3
  • pone.0196434.s001.xlsx, sheet 2
View BVdb publication page



Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation.

Cancer Treatment Reviews
Ferris, Robert L RL; Lenz, Heinz-Josef HJ; Trotta, Anna Maria AM; García-Foncillas, Jesús J; Schulten, Jeltje J; Audhuy, François F; Merlano, Marco M; Milano, Gerard G
Publication Date: 2018-02

Variant appearance in text: NRAS: H131R
PubMed Link: 29223828
Variant Present in the following documents:
  • Main text
  • nihms-1623487.pdf
View BVdb publication page



Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.

Oncotarget
John, Bincy Anu BA; Said, Neveen N
Publication Date: 2017-08-22

Variant appearance in text: NRAS: H131R
PubMed Link: 28915710
Variant Present in the following documents:
  • Main text
  • oncotarget-08-57766.pdf
View BVdb publication page



NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.

Molecular Oncology
Cirenajwis, Helena H; Lauss, Martin M; Ekedahl, Henrik H; Törngren, Therese T; Kvist, Anders A; Saal, Lao H LH; Olsson, Håkan H; Staaf, Johan J; Carneiro, Ana A; Ingvar, Christian C; Harbst, Katja K; Hayward, Nicholas K NK; Jönsson, Göran G
Publication Date: 2017-04

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 28267273
Variant Present in the following documents:
  • MOL2-11-438-s003.xls, sheet 1
View BVdb publication page



Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.

World Journal Of Gastroenterology
Lo Nigro, Cristiana C; Ricci, Vincenzo V; Vivenza, Daniela D; Granetto, Cristina C; Fabozzi, Teresa T; Miraglio, Emanuela E; Merlano, Marco C MC
Publication Date: 2016-08-14

Variant appearance in text: NRAS: H131R
PubMed Link: 27570430
Variant Present in the following documents:
  • Main text
View BVdb publication page



A Landscape of Pharmacogenomic Interactions in Cancer.

Cell
Iorio, Francesco F; Knijnenburg, Theo A TA; Vis, Daniel J DJ; Bignell, Graham R GR; Menden, Michael P MP; Schubert, Michael M; Aben, Nanne N; Gonçalves, Emanuel E; Barthorpe, Syd S; Lightfoot, Howard H; Cokelaer, Thomas T; Greninger, Patricia P; van Dyk, Ewald E; Chang, Han H; de Silva, Heshani H; Heyn, Holger H; Deng, Xianming X; Egan, Regina K RK; Liu, Qingsong Q; Mironenko, Tatiana T; Mitropoulos, Xeni X; Richardson, Laura L; Wang, Jinhua J; Zhang, Tinghu T; Moran, Sebastian S; Sayols, Sergi S; Soleimani, Maryam M; Tamborero, David D; Lopez-Bigas, Nuria N; Ross-Macdonald, Petra P; Esteller, Manel M; Gray, Nathanael S NS; Haber, Daniel A DA; Stratton, Michael R MR; Benes, Cyril H CH; Wessels, Lodewyk F A LFA; Saez-Rodriguez, Julio J; McDermott, Ultan U; Garnett, Mathew J MJ
Publication Date: 2016-07-28

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 27397505
Variant Present in the following documents:
  • mmc3.xlsx, sheet 3
View BVdb publication page



Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients.

World Journal Of Gastrointestinal Oncology
Lo Nigro, Cristiana C; Ricci, Vincenzo V; Vivenza, Daniela D; Monteverde, Martino M; Strola, Giuliana G; Lucio, Francesco F; Tonissi, Federica F; Miraglio, Emanuela E; Granetto, Cristina C; Fortunato, Mirella M; Merlano, Marco Carlo MC
Publication Date: 2016-02-15

Variant appearance in text: NRAS: H131R
PubMed Link: 26909137
Variant Present in the following documents:
  • Main text
View BVdb publication page



LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.

Bmc Bioinformatics
Melloni, Giorgio E M GE; de Pretis, Stefano S; Riva, Laura L; Pelizzola, Mattia M; Céol, Arnaud A; Costanza, Jole J; Müller, Heiko H; Zammataro, Luca L
Publication Date: 2016-02-09

Variant appearance in text: NRAS: H131R
PubMed Link: 26860319
Variant Present in the following documents:
  • 12859_2016_935_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Recurrent inactivating RASA2 mutations in melanoma.

Nature Genetics
Arafeh, Rand R; Qutob, Nouar N; Emmanuel, Rafi R; Keren-Paz, Alona A; Madore, Jason J; Elkahloun, Abdel A; Wilmott, James S JS; Gartner, Jared J JJ; Di Pizio, Antonella A; Winograd-Katz, Sabina S; Sindiri, Sivasish S; Rotkopf, Ron R; Dutton-Regester, Ken K; Johansson, Peter P; Pritchard, Antonia L AL; Waddell, Nicola N; Hill, Victoria K VK; Lin, Jimmy C JC; Hevroni, Yael Y; Rosenberg, Steven A SA; Khan, Javed J; Ben-Dor, Shifra S; Niv, Masha Y MY; Ulitsky, Igor I; Mann, Graham J GJ; Scolyer, Richard A RA; Hayward, Nicholas K NK; Samuels, Yardena Y
Publication Date: 2015-12

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 26502337
Variant Present in the following documents:
  • NIHMS65345-supplement-Supplementary_table_3.xlsx, sheet 1
  • NIHMS65345-supplement-Supplementary_table_1.xlsx, sheet 1
View BVdb publication page



A highly recurrent RPS27 5'UTR mutation in melanoma.

Oncotarget
Dutton-Regester, Ken K; Gartner, Jared J JJ; Emmanuel, Rafi R; Qutob, Nouar N; Davies, Michael A MA; Gershenwald, Jeffrey E JE; Robinson, William W; Robinson, Steven S; Rosenberg, Steven A SA; Scolyer, Richard A RA; Mann, Graham J GJ; Thompson, John F JF; Hayward, Nicholas K NK; Samuels, Yardena Y
Publication Date: 2014-05-30

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 24913145
Variant Present in the following documents:
  • oncotarget-05-2912-s003.xlsx, sheet 1
View BVdb publication page



FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.

Bmc Cancer
Kjersem, Janne B JB; Skovlund, Eva E; Ikdahl, Tone T; Guren, Tormod T; Kersten, Christian C; Dalsgaard, Astrid M AM; Yilmaz, Mette K MK; Fokstuen, Tone T; Tveit, Kjell M KM; Kure, Elin H EH
Publication Date: 2014-05-19

Variant appearance in text: NRAS: H131R
PubMed Link: 24884501
Variant Present in the following documents:
  • Main text
  • 1471-2407-14-340.pdf
View BVdb publication page



Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.

Contemporary Oncology (Poznan, Poland)
Krawczyk, Paweł Adam PA; Kowalski, Dariusz M DM
Publication Date: 2014

Variant appearance in text: NRAS: H131R
PubMed Link: 24876815
Variant Present in the following documents:
  • Main text
View BVdb publication page



A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.

Molecular Cancer Therapeutics
Xia, Junfeng J; Jia, Peilin P; Hutchinson, Katherine E KE; Dahlman, Kimberly B KB; Johnson, Douglas D; Sosman, Jeffrey J; Pao, William W; Zhao, Zhongming Z
Publication Date: 2014-07

Variant appearance in text: NRAS: 392A>G; H131R
PubMed Link: 24755198
Variant Present in the following documents:
  • Main text
View BVdb publication page



Integrating anti-EGFR therapies in metastatic colorectal cancer.

Journal Of Gastrointestinal Oncology
Haraldsdottir, Sigurdis S; Bekaii-Saab, Tanios T
Publication Date: 2013-09

Variant appearance in text: NRAS: H131R
PubMed Link: 23997940
Variant Present in the following documents:
  • Main text
View BVdb publication page



A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer.

Journal Of Hematology & Oncology
Mellor, James D JD; Brown, Michael P MP; Irving, Helen R HR; Zalcberg, John R JR; Dobrovic, Alexander A
Publication Date: 2013-01-04

Variant appearance in text: NRAS: His131Arg
PubMed Link: 23286345
Variant Present in the following documents:
  • Main text
  • 1756-8722-6-1.pdf
View BVdb publication page